-+ 0.00%
-+ 0.00%
-+ 0.00%

DataMeds AI Enters At-the-Market Stock Sales Agreement With Dawson James

PUBT·11/16/2026 11:20:30
Listen to the news
DataMeds AI Enters At-the-Market Stock Sales Agreement With Dawson James
  • DataMeds AI entered an at-the-market common stock sales agreement with Dawson James Securities on November 16, 2026.
  • The sales agent will receive a 3% commission on aggregate gross proceeds.
  • The company has no obligation to sell shares and may set minimum sale prices.
  • Either party may terminate the agreement at its sole discretion with 10 days’ prior notice.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DataMeds AI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-051924), on November 16, 2026, and is solely responsible for the information contained therein.